TLSI
Income statement / Annual
Last year (2023), TriSalus Life Sciences, Inc.'s total revenue was $18.51 M,
an increase of 49.31% from the previous year.
In 2023, TriSalus Life Sciences, Inc.'s net income was -$59.04 M.
See TriSalus Life Sciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$18.51 M
|
$12.40 M
|
$8.40 M
|
$5.43 M
|
| Cost of Revenue |
$2.61 M |
$2.26 M |
$1.19 M |
$2.20 M |
| Gross Profit |
$15.91 M |
$10.14 M |
$7.21 M |
$3.24 M |
| Gross Profit Ratio |
0.86 |
0.82 |
0.86 |
0.6 |
| Research and Development
Expenses |
$29.51 M
|
$21.36 M
|
$14.22 M
|
$15.83 M
|
| General & Administrative
Expenses |
$23.51 M
|
$12.48 M
|
$8.75 M
|
$6.87 M
|
| Selling & Marketing
Expenses |
$17.03 M
|
$12.74 M
|
$8.26 M
|
$6.19 M
|
| Selling, General &
Administrative Expenses |
$40.55 M
|
$25.22 M
|
$17.02 M
|
$13.06 M
|
| Other Expenses |
$0.00 |
-$8.73 M |
$746,000.00 |
$0.00 |
| Operating Expenses |
$70.06 M |
$46.58 M |
$31.24 M |
$29.02 M |
| Cost And Expenses |
$72.66 M |
$48.84 M |
$32.43 M |
$31.22 M |
| Interest Income |
$431,000.00 |
$180,000.00 |
$63,997.00 |
$0.00 |
| Interest Expense |
$16,000.00 |
$1,000.00 |
$1.76 M |
$0.00 |
| Depreciation &
Amortization |
$702,000.00
|
$414,000.00
|
$464,000.00
|
$321,000.00
|
| EBITDA |
-$58.30 M
|
-$46.76 M
|
-$23.57 M
|
-$25.33 M
|
| EBITDA Ratio |
-3.15 |
-3.6 |
-2.72 |
-4.66 |
| Operating Income Ratio
|
-2.93
|
-2.94
|
-2.86
|
-4.72
|
| Total Other
Income/Expenses Net |
-$4.88 M
|
-$10.74 M
|
-$4.81 M
|
-$6.18 M
|
| Income Before Tax |
-$59.03 M |
-$47.18 M |
-$28.84 M |
-$31.83 M |
| Income Before Tax Ratio
|
-3.19
|
-3.81
|
-3.43
|
-5.86
|
| Income Tax Expense |
$9,000.00 |
$9,000.00 |
$3,000.00 |
$4,000.00 |
| Net Income |
-$59.04 M |
-$47.19 M |
-$28.85 M |
-$31.83 M |
| Net Income Ratio |
-3.19 |
-3.81 |
-3.43 |
-5.86 |
| EPS |
-6.73 |
-1.59 |
-0.92 |
-1.04 |
| EPS Diluted |
-6.73 |
-1.59 |
-0.92 |
-1.04 |
| Weighted Average Shares
Out |
$9.40 M
|
$29.61 M
|
$31.25 M
|
$30.56 M
|
| Weighted Average Shares
Out Diluted |
$9.40 M
|
$29.61 M
|
$31.25 M
|
$30.56 M
|
| Link |
|
|
|
|
